PRSS38
gene geneOn this page
Also known as MPN2
Summary
PRSS38 (serine protease 38, HGNC:29625) is a protein-coding gene on chromosome 1q42.13, encoding Serine protease 38 (A1L453).
Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be located in extracellular region.
Source: NCBI Gene 339501 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 81 total — 1 pathogenic
- MANE Select transcript:
NM_183062
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29625 |
| Approved symbol | PRSS38 |
| Name | serine protease 38 |
| Location | 1q42.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MPN2 |
| Ensembl gene | ENSG00000185888 |
| Ensembl biotype | protein_coding |
| Entrez | 339501 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000366757
RefSeq mRNA: 2 — MANE Select: NM_183062
NM_001374657, NM_183062
CCDS: CCDS1563
Canonical transcript exons
ENST00000366757 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001307099 | 227845954 | 227846470 |
| ENSE00001311352 | 227816090 | 227816252 |
| ENSE00001318785 | 227817209 | 227817480 |
| ENSE00001324461 | 227845470 | 227845612 |
| ENSE00003978215 | 227815675 | 227815864 |
Expression profiles
Bgee: expression breadth tissue_specific, 10 present calls, max score 85.12.
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| quadriceps femoris | UBERON:0001377 | 85.12 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.26 | gold quality |
| cerebellar vermis | UBERON:0004720 | 81.32 | gold quality |
| right testis | UBERON:0004534 | 64.52 | gold quality |
| left testis | UBERON:0004533 | 63.23 | gold quality |
| testis | UBERON:0000473 | 63.05 | gold quality |
| thymus | UBERON:0002370 | 58.60 | silver quality |
| colonic epithelium | UBERON:0000397 | 45.64 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 38.40 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.70 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| granulocyte | CL:0000094 | 36.42 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| sural nerve | UBERON:0015488 | 35.93 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle tissue | UBERON:0002385 | 34.28 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 32.10 | gold quality |
| urinary bladder | UBERON:0001255 | 31.87 | gold quality |
| right uterine tube | UBERON:0001302 | 31.65 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 29.81 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.60 | gold quality |
| liver | UBERON:0002107 | 28.88 | gold quality |
| blood | UBERON:0000178 | 28.87 | gold quality |
| tonsil | UBERON:0002372 | 28.52 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| leukocyte | CL:0000738 | 27.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting PRSS38, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-3944-5P | 98.50 | 67.55 | 997 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-4708-5P | 97.77 | 67.82 | 831 |
| HSA-MIR-4288 | 97.11 | 67.23 | 1636 |
| HSA-MIR-632 | 96.08 | 67.17 | 798 |
| HSA-MIR-5587-3P | 82.90 | 60.79 | 138 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ctrl | ENSDARG00000068680 |
| danio_rerio | si:dkey-238d18.3 | ENSDARG00000088893 |
| danio_rerio | zgc:171592 | ENSDARG00000101964 |
| mus_musculus | Prss38 | ENSMUSG00000049291 |
| rattus_norvegicus | Prss38 | ENSRNOG00000022548 |
Paralogs (1): CTRL (ENSG00000141086)
Protein
Protein identifiers
Serine protease 38 — A1L453 (reviewed: A1L453)
Alternative names: Marapsin-2
All UniProt accessions (1): A1L453
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the peptidase S1 family.
RefSeq proteins (2): NP_001361586, NP_898885* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001254 | Trypsin_dom | Domain |
| IPR001314 | Peptidase_S1A | Family |
| IPR009003 | Peptidase_S1_PA | Homologous_superfamily |
| IPR018114 | TRYPSIN_HIS | Active_site |
| IPR033116 | TRYPSIN_SER | Active_site |
| IPR043504 |
Pfam: PF00089
UniProt features (14 total): disulfide bond 4, active site 3, signal peptide 1, propeptide 1, sequence variant 1, sequence conflict 1, chain 1, domain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A1L453-F1 | 82.03 | 0.55 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 100 (charge relay system); 150 (charge relay system); 245 (charge relay system)
Disulfide bonds (4): 214–230, 241–269, 85–101, 183–251
Glycosylation sites (1): 125
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 9 (showing top):
GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, NFE2L2.V2, GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP, GOMF_SERINE_HYDROLASE_ACTIVITY, NOURUZI_NEPC_ASCL1_TARGETS, GOMF_ENDOPEPTIDASE_ACTIVITY, GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP, chr1q42
GO Biological Process (1): proteolysis (GO:0006508)
GO Molecular Function (4): serine-type endopeptidase activity (GO:0004252), peptidase activity (GO:0008233), serine-type peptidase activity (GO:0008236), hydrolase activity (GO:0016787)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 1 |
| endopeptidase activity | 1 |
| serine-type peptidase activity | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| peptidase activity | 1 |
| serine hydrolase activity | 1 |
| catalytic activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
306 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRSS38 | USB1 | Q9BQ65 | 597 |
| PRSS38 | FAM227A | F5H4B4 | 527 |
| PRSS38 | PPIAL4C | A0A0B4J2A2 | 513 |
| PRSS38 | PPIAL4E | A0A075B759 | 506 |
| PRSS38 | PPIAL4G | P0DN37 | 478 |
| PRSS38 | PPIAL4A | Q9Y536 | 433 |
| PRSS38 | CFAP251 | Q8TBY9 | 321 |
| PRSS38 | ZPBP | Q9BS86 | 318 |
| PRSS38 | TSEN2 | Q8NCE0 | 300 |
| PRSS38 | ZC2HC1C | Q53FD0 | 286 |
| PRSS38 | FMR1 | Q06787 | 278 |
| PRSS38 | ZP1 | P60852 | 236 |
| PRSS38 | ZNF100 | Q8IYN0 | 225 |
| PRSS38 | ITPRIPL2 | Q3MIP1 | 220 |
| PRSS38 | C5orf34 | Q96MH7 | 217 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OTUB1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): PRSS38 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GVH4, A1L453, A4D1T9, A6H6T1, A8MTI9, A8QL53, A8QL57, B5U6Y3, E5RG02, O35453, O70169, P00745, P04070, P08709, P0CG03, P0DJE9, P22891, Q14BX2, Q28278, Q28661, Q2F9P2, Q2F9P4, Q2TV78, Q3V0Q7, Q402U7, Q4R7Y7, Q5FBW1, Q5M8S2, Q6AXZ6, Q6AY28, Q6IE62, Q6IE63, Q6PEW0, Q6UWB4, Q76HL1, Q7M756, Q7M761, Q7RTY5, Q7RTY7, Q7Z5A4
Diamond homologs: A0A1B0GVH4, A1L453, A2VE36, E5RG02, F2YMG0, O35205, O35453, O60235, O97370, P03952, P05981, P06868, P08001, P08709, P10323, P14272, P19236, P20231, P22457, P23578, P26262, P29293, P29786, P35035, P35036, P35038, P35039, P35040, P35041, P39675, P49275, P49864, P50342, P69526, P70375, P83748, P98139, Q05511, Q14B25, Q14BX2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 65 |
| Likely benign | 5 |
| Benign | 9 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1708464 | GRCh37/hg19 1q31.3-44(chr1:197867914-249224684)x3 | Pathogenic |
SpliceAI
905 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:227816249:ACAGG:A | donor_loss | 1.0000 |
| 1:227816250:CAGGT:C | donor_loss | 1.0000 |
| 1:227816253:GTAA:G | donor_loss | 1.0000 |
| 1:227845464:CCACA:C | acceptor_loss | 1.0000 |
| 1:227845465:CACA:C | acceptor_loss | 1.0000 |
| 1:227845467:CA:C | acceptor_loss | 1.0000 |
| 1:227845469:G:A | acceptor_loss | 1.0000 |
| 1:227845469:GGT:G | acceptor_gain | 1.0000 |
| 1:227845596:C:G | donor_gain | 1.0000 |
| 1:227845600:GACC:G | donor_gain | 1.0000 |
| 1:227815840:G:GT | donor_gain | 0.9900 |
| 1:227815841:G:T | donor_gain | 0.9900 |
| 1:227815859:GC:G | donor_gain | 0.9900 |
| 1:227816253:G:GG | donor_gain | 0.9900 |
| 1:227816254:T:G | donor_loss | 0.9900 |
| 1:227817420:G:GT | donor_gain | 0.9900 |
| 1:227845468:AGGT:A | acceptor_gain | 0.9900 |
| 1:227845469:GGTG:G | acceptor_gain | 0.9900 |
| 1:227845469:GGTGA:G | acceptor_gain | 0.9900 |
| 1:227845595:GC:G | donor_gain | 0.9900 |
| 1:227845604:GTGT:G | donor_gain | 0.9900 |
| 1:227816250:CAG:C | donor_gain | 0.9800 |
| 1:227845468:A:AG | acceptor_gain | 0.9800 |
| 1:227845468:AG:A | acceptor_gain | 0.9800 |
| 1:227845469:G:GG | acceptor_gain | 0.9800 |
| 1:227845469:GG:G | acceptor_gain | 0.9800 |
| 1:227845596:C:CG | donor_gain | 0.9800 |
| 1:227845607:TGTG:T | donor_gain | 0.9800 |
| 1:227815788:G:GA | donor_gain | 0.9700 |
| 1:227816213:A:AG | donor_gain | 0.9700 |
AlphaMissense
2095 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:227817461:G:C | W188C | 0.994 |
| 1:227817461:G:T | W188C | 0.994 |
| 1:227817351:G:C | A152P | 0.992 |
| 1:227846088:G:C | W287C | 0.991 |
| 1:227846088:G:T | W287C | 0.991 |
| 1:227816160:G:C | W73C | 0.988 |
| 1:227816160:G:T | W73C | 0.988 |
| 1:227816203:T:C | S88P | 0.988 |
| 1:227816158:T:A | W73R | 0.987 |
| 1:227816158:T:C | W73R | 0.987 |
| 1:227845574:T:A | C230S | 0.986 |
| 1:227845575:G:C | C230S | 0.986 |
| 1:227846017:A:C | S264R | 0.986 |
| 1:227846019:C:A | S264R | 0.986 |
| 1:227846019:C:G | S264R | 0.986 |
| 1:227816167:A:C | S76R | 0.984 |
| 1:227816169:C:A | S76R | 0.984 |
| 1:227816169:C:G | S76R | 0.984 |
| 1:227817352:C:A | A152D | 0.984 |
| 1:227817355:T:C | L153P | 0.983 |
| 1:227846086:T:A | W287R | 0.983 |
| 1:227846086:T:C | W287R | 0.983 |
| 1:227817459:T:A | W188R | 0.982 |
| 1:227817459:T:C | W188R | 0.982 |
| 1:227816154:G:C | W71C | 0.980 |
| 1:227816154:G:T | W71C | 0.980 |
| 1:227816228:T:C | L96P | 0.979 |
| 1:227816244:C:G | C101W | 0.979 |
| 1:227845973:T:C | L249P | 0.979 |
| 1:227816207:T:A | I89N | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000030476 (1:227821459 T>A,C), RS1000162537 (1:227813911 G>A), RS1000594977 (1:227825018 T>C,G), RS1000651610 (1:227845128 C>A), RS1000789939 (1:227838859 A>T), RS1000907669 (1:227815707 C>G,T), RS1000909959 (1:227837867 G>A,T), RS1000920139 (1:227821801 T>A), RS1000968329 (1:227843953 A>T), RS1001043634 (1:227831815 G>A), RS1001221728 (1:227833787 A>G), RS1001418784 (1:227831603 G>A), RS1001483260 (1:227834001 T>G), RS1001746268 (1:227816441 T>C), RS1001773753 (1:227846077 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003542_210 | Night sleep phenotypes | 7.000000e-06 |
| GCST010244_155 | Triglyceride levels | 2.000000e-11 |
| GCST90020029_639 | Waist circumference adjusted for body mass index | 3.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol S | increases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Diazinon | decreases methylation | 1 |
| Endosulfan | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.